A novel sensitive and selective bioassay for human type I interferons

Journal of Interferon and Cytokine Research

Volumn 18, Issue 12, 1998, Pages 1019-1024

  Files, James G ^a   Gray, Julia L ^a   Do, Linh T ^a   Foley, Wayne P ^a   Gabe, Jeffrey D ^a   Nestaas, Eirik ^a   Pungor Jr , Erno ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; INTERFERON BETA SERINE; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; BIOASSAY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG DETERMINATION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; SERUM; TUMOR CELL LINE;

EID: 0032425162     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.1019     Document Type: Article

References (25)

1. KAWADE, Y., and WATANABE, Y. (1984). Neutralization of interferon by antibody: appraisals of methods of determining and expressing the neutralization titer. J. Interferon Res. 4, 571-584.
2. FIERLBECK, G., and SCHREINER, T. (1994). Incidence and clinical significance of therapy-induced neutralizing antibodies against interferon-beta. J. Interferon Res. 14, 205-206.
3. JAMESON, P., and GROSSBERG, S.E. (1981). Virus yield reduction assays for interferon: picornavirus hemagglutination measurements. Methods Enzymol. 78, 357-368.
4. JOHNSTON, M.D., FINTER, N.B., and YOUNG, P.A. (1981). Dye uptake method for assay of Interferon activity. Methods Enzymol. 78, 394-398.
5. CANOSI, U., MASCIA, M., GAZZA, L., SERLUPI-CRESCENZI, O., DONINI, S., ANTONETTI, F., and GALLI, G. (1996). A highly precise reporter gene bioassay for type I Interferon. J. Immunol. Methods 199, 69-76.
6. LLEONART, R., NAF, D., BROWNING, H., and WEISSMANN, C. (1990). A novel, quantitative bioassay for type I Interferon using a recombinant indicator cell line. Biotechnology N.Y. 8, 1263-1267.
7. VON WUSSOW, P., JAKSCHIES, D., HOCHKEPPEL, H.-K., FIBICH, C., PENNER, L., and DEICHER, H. (1990). The human intracellular Mx-homologous protein is specifically induced by type I interferons. Eur. J. Immunol. 20, 2015-2019.
8. SIMON, A., FAH, J., HALLER, O., and STAEHELI, P. (1991). Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J. Virol. 65, 968-971.
9. PAVLOVIC, J., and STAEHELI, P. (1991). The antiviral potentials of Mx proteins. J. Interferon Res. 11, 215-219.
10. MELEN, K., RONNI, T., LOTTA, T., and JULKUNEN, I. (1994). Enzymatic characterization of interferon-induced antiviral GTPases murine Mx1 and human MxA proteins. J. Biol. Chem. 269, 2009-2015.
11. SCHNORR, J.J., SCHNEIDER-SCHAULIES, S., SIMON-JODICKE, A., PAVLOVIC, J., HORISBERGER, M.A., and TER MEULEN, V. (1993). MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67,4760-4768.
12. TOWBIN, H., SCHMITZ, A., JAKSCHIES, D., VON WUSSOW, P., and HORISBERGER, M.A. (1992). A whole blood immunoassay for the interferon-inducible human Mx protein. J. Interferon Res. 12, 67-74.
13. JAKSCHIES, D., HOCHKEPPEL, H., HORISBERGER, M.A., DEICHER, H., and VON WUSSOW, P. (1990). Emergence and decay of the human Mx homolog in cancer patients during and after interferon-α therapy. J. Biol. Response Mod. 9, 305-312.
14. ROERS, A., HOCHKEPPEL, H.K., HORISBERGER, M.A., HOVANESSIAN, A., and HALLER, O. (1994). MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Dis. 169, 807-813.
15. OH, S.-K., LUHOWSKYJ, S., WITT, P., RITCH, P., REITSMA, D., TOWBIN, H., HORISBERGER, M., VON WUSSOW, P., and BLUESTEIN, B. (1994). Quantitation of interferon-induced Mx protein in whole blood lysates by an immunochemiluminescent assay: elimination of protease activity of cell lysates in toto. J. Immunol. Methods 176, 79-91.
16. RONNI, T., MELEN, K., MALYGIN, A., and JULKUNEN, I. (1993). Control of IFN-inducible MxA gene expression in human cells. J. Immunol. 150, 1715-1726.
17. HORISBERGER, M.A. (1992). Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 66, 4705-4709.
18. LEVY, D.E., LEW, D.J., DECKER, T., KESSLER, D.S., and DARNELL, J.E. (1990). Synergistic interaction between interferon-α and interferon-γ through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 9, 1105-1111.
19. SCHILLER, J.H., HORISBERGER, M.A., BITTNER, G., CARLIN, J.M., STORER, B., BYRNE, G.I., WILLSON, J.K., and BORDEN, E.C. (1990). Effects of combinations of interferon-betaser and interferon γ on interferon-inducible proteins and on the cell cycle. J. Biol. Response Mod. 9, 368-377.
20. THOMIS, D.C., and SAMUEL, C.E. (1992). Mechanism of interferon action: alpha and γ interferons differentially affect mRNA levels of the catalytic subunit of protein kinase A and protein Mx in human cells. J. Virol. 66, 2519-2522.
21. Research Reference Reagent Note No. 45. (1995). Freeze-dried human anti-human interferon-beta antibody reference Catalog Number G038-501-572. Research resources Section, National Institute of Allergy and Infectious Diseases. Bethesda, MD: NIH.
22. CONSTANTTNESCU, S.N., CROZE, E., MURTI, A., WANG, C., BASU, L., HOLLANDER, D., RUSSEL-HARDE, D., BETTS, M., GARCIA-MARTINEZ, V., MULLERSMAN, J.E., and PFEFFER, L.M. (1995). Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex. Proc. Natl. Acad. Sci. USA 92, 10487-10491.
23. NOVICK, D., COHEN, B., and RUBINSTEIN, M. (1994). The human interferon α/β receptor: characterization and molecular cloning. Cell 77, 391-400.
24. PUNGOR, E., JR., FILES, J.G., GABE, J.D., DO, L.T., FOLEY, W.P., GRAY, J.L., NELSON, J.W., NESTAAS, E., TAYLOR, J.L., and GROSSBERG, S.E. (1988). A novel bioassay for the determination of neutralizing antibodies to IFN-β1b. J. Interferon Cytokine Res. 18, 1025-1030.
25. LAROCCA, A.P., LEUNG, S.C., and MARCUS, S.G. (1989). Evaluation of neutralizing antibodies in patients treated with recombinant interferon, Betaseron. J. Interferon Res. 9(Suppl. 1), 51-60.